NCT02115308View on ClinicalTrials.gov

Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 3, 2014

Primary Completion Date

January 16, 2018

Study Completion Date

March 23, 2018

Conditions
Coronary Artery Disease
Interventions
DRUG

Regadenoson

Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging.

Trial Locations (1)

64111

Saint Luke's Health System, Kansas City

All Listed Sponsors
collaborator

Saint Luke's Health System

OTHER

collaborator

Saint Luke's Cardiovascular Consultants

OTHER

lead

Timothy M. Bateman

OTHER

NCT02115308 - Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter